(GRC) Gorman-Rupp - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US3830821043
Stock: Pumps, Systems, Centrifugal, Submersible, Dewatering
Total Rating 67
Risk 89
Buy Signal 1.23
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.84% |
| Yield on Cost 5y | 3.11% |
| Yield CAGR 5y | 4.07% |
| Payout Consistency | 95.3% |
| Payout Ratio | 35.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 29.1% |
| Relative Tail Risk | -9.58% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.95 |
| Alpha | 62.28 |
| Character TTM | |
|---|---|
| Beta | 0.962 |
| Beta Downside | 0.865 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.87% |
| CAGR/Max DD | 1.33 |
Description: GRC Gorman-Rupp January 20, 2026
Gorman-Rupp (NYSE:GRC) designs, manufactures and sells a broad portfolio of pumps-including self-priming, magnetic-drive, submersible and high-pressure booster units-for water, wastewater, construction, petroleum, agricultural and fire-suppression applications, serving customers worldwide through distributors, OEM partners, direct sales and e-commerce channels.
In FY 2023 the company generated roughly $1.1 billion in revenue, posting an adjusted EBITDA margin of about 13% and a year-over-year earnings-per-share increase of 8%, while its order backlog rose to $210 million, indicating solid demand continuity.
Key macro drivers for Gorman-Rupp include rising U.S. federal and state infrastructure spending on water and wastewater projects, which the American Society of Civil Engineers rates as a high-priority need, and sustained construction activity that fuels demand for dewatering and high-pressure pump solutions.
For a deeper, data-rich perspective on Gorman-Rupp’s valuation and risk profile, you may want to explore the company’s analyst metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 53.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 5.32 > 1.0 |
| NWC/Revenue: 19.80% < 20% (prev 20.21%; Δ -0.41% < -1%) |
| CFO/TA 0.12 > 3% & CFO 106.2m > Net Income 53.0m |
| Net Debt (-35.1m) to EBITDA (120.4m): -0.29 < 3 |
| Current Ratio: 2.37 > 1.5 & < 3 |
| Outstanding Shares: last quarter (25.0m) vs 12m ago -4.69% < -2% |
| Gross Margin: 30.20% > 18% (prev 0.31%; Δ 2989 % > 0.5%) |
| Asset Turnover: 79.42% > 50% (prev 76.84%; Δ 2.57% > 0%) |
| Interest Coverage Ratio: 3.96 > 6 (EBITDA TTM 120.4m / Interest Expense TTM 23.4m) |
Altman Z'' 5.34
| A: 0.16 (Total Current Assets 233.7m - Total Current Liabilities 98.6m) / Total Assets 860.1m |
| B: 0.48 (Retained Earnings 409.8m / Total Assets 860.1m) |
| C: 0.11 (EBIT TTM 92.7m / Avg Total Assets 859.3m) |
| D: 1.93 (Book Value of Equity 860.1m / Total Liabilities 445.3m) |
| Altman-Z'' Score: 5.34 = AAA |
Beneish M -3.07
| DSRI: 0.97 (Receivables 88.4m/87.6m, Revenue 682.4m/659.7m) |
| GMI: 1.01 (GM 30.20% / 30.51%) |
| AQI: 1.01 (AQ_t 0.57 / AQ_t-1 0.57) |
| SGI: 1.03 (Revenue 682.4m / 659.7m) |
| TATA: -0.06 (NI 53.0m - CFO 106.2m) / TA 860.1m) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of GRC shares?
As of February 10, 2026, the stock is trading at USD 65.93 with a total of 326,631 shares traded.
Over the past week, the price has changed by +16.94%, over one month by +30.14%, over three months by +48.81% and over the past year by +81.77%.
Over the past week, the price has changed by +16.94%, over one month by +30.14%, over three months by +48.81% and over the past year by +81.77%.
Is GRC a buy, sell or hold?
Gorman-Rupp has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy GRC.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GRC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 66.5 | 0.9% |
| Analysts Target Price | 66.5 | 0.9% |
| ValueRay Target Price | 86.5 | 31.2% |
GRC Fundamental Data Overview February 09, 2026
P/E Trailing = 32.5248
P/E Forward = 19.6464
P/S = 2.5334
P/B = 4.1685
P/EG = 1.5117
Revenue TTM = 682.4m USD
EBIT TTM = 92.7m USD
EBITDA TTM = 120.4m USD
Long Term Debt = 301.5m USD (from longTermDebt, two quarters ago)
Short Term Debt = 23.1m USD (from shortTermDebt, last quarter)
Debt = 307.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -35.1m USD (from netDebt column, last quarter)
Enterprise Value = 2.00b USD (1.73b + Debt 307.5m - CCE 35.1m)
Interest Coverage Ratio = 3.96 (Ebit TTM 92.7m / Interest Expense TTM 23.4m)
EV/FCF = 19.74x (Enterprise Value 2.00b / FCF TTM 101.4m)
FCF Yield = 5.07% (FCF TTM 101.4m / Enterprise Value 2.00b)
FCF Margin = 14.86% (FCF TTM 101.4m / Revenue TTM 682.4m)
Net Margin = 7.77% (Net Income TTM 53.0m / Revenue TTM 682.4m)
Gross Margin = 30.20% ((Revenue TTM 682.4m - Cost of Revenue TTM 476.3m) / Revenue TTM)
Gross Margin QoQ = 31.42% (prev 27.39%)
Tobins Q-Ratio = 2.33 (Enterprise Value 2.00b / Total Assets 860.1m)
Interest Expense / Debt = 1.73% (Interest Expense 5.31m / Debt 307.5m)
Taxrate = 23.25% (4.16m / 17.9m)
NOPAT = 71.1m (EBIT 92.7m * (1 - 23.25%))
Current Ratio = 2.37 (Total Current Assets 233.7m / Total Current Liabilities 98.6m)
Debt / Equity = 0.36 (Debt 307.5m / totalStockholderEquity, last quarter 860.1m)
Debt / EBITDA = -0.29 (Net Debt -35.1m / EBITDA 120.4m)
Debt / FCF = -0.35 (Net Debt -35.1m / FCF TTM 101.4m)
Total Stockholder Equity = 511.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.17% (Net Income 53.0m / Total Assets 860.1m)
RoE = 10.37% (Net Income TTM 53.0m / Total Stockholder Equity 511.3m)
RoCE = 11.40% (EBIT 92.7m / Capital Employed (Equity 511.3m + L.T.Debt 301.5m))
RoIC = 9.71% (NOPAT 71.1m / Invested Capital 732.2m)
WACC = 8.23% (E(1.73b)/V(2.04b) * Re(9.46%) + D(307.5m)/V(2.04b) * Rd(1.73%) * (1-Tc(0.23)))
Discount Rate = 9.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -2.31%
[DCF Debug] Terminal Value 80.51% ; FCFF base≈83.0m ; Y1≈102.4m ; Y5≈174.4m
Fair Price DCF = 108.3 (EV 2.82b - Net Debt -35.1m = Equity 2.85b / Shares 26.3m; r=8.23% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 75.55 | EPS CAGR: 18.61% | SUE: 0.72 | # QB: 0
Revenue Correlation: 70.83 | Revenue CAGR: 13.92% | SUE: -0.14 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.53 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=2.25 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+5.1% | Growth Revenue=+6.0%
EPS next Year (2027-12-31): EPS=2.52 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+12.0% | Growth Revenue=+3.5%
P/E Forward = 19.6464
P/S = 2.5334
P/B = 4.1685
P/EG = 1.5117
Revenue TTM = 682.4m USD
EBIT TTM = 92.7m USD
EBITDA TTM = 120.4m USD
Long Term Debt = 301.5m USD (from longTermDebt, two quarters ago)
Short Term Debt = 23.1m USD (from shortTermDebt, last quarter)
Debt = 307.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -35.1m USD (from netDebt column, last quarter)
Enterprise Value = 2.00b USD (1.73b + Debt 307.5m - CCE 35.1m)
Interest Coverage Ratio = 3.96 (Ebit TTM 92.7m / Interest Expense TTM 23.4m)
EV/FCF = 19.74x (Enterprise Value 2.00b / FCF TTM 101.4m)
FCF Yield = 5.07% (FCF TTM 101.4m / Enterprise Value 2.00b)
FCF Margin = 14.86% (FCF TTM 101.4m / Revenue TTM 682.4m)
Net Margin = 7.77% (Net Income TTM 53.0m / Revenue TTM 682.4m)
Gross Margin = 30.20% ((Revenue TTM 682.4m - Cost of Revenue TTM 476.3m) / Revenue TTM)
Gross Margin QoQ = 31.42% (prev 27.39%)
Tobins Q-Ratio = 2.33 (Enterprise Value 2.00b / Total Assets 860.1m)
Interest Expense / Debt = 1.73% (Interest Expense 5.31m / Debt 307.5m)
Taxrate = 23.25% (4.16m / 17.9m)
NOPAT = 71.1m (EBIT 92.7m * (1 - 23.25%))
Current Ratio = 2.37 (Total Current Assets 233.7m / Total Current Liabilities 98.6m)
Debt / Equity = 0.36 (Debt 307.5m / totalStockholderEquity, last quarter 860.1m)
Debt / EBITDA = -0.29 (Net Debt -35.1m / EBITDA 120.4m)
Debt / FCF = -0.35 (Net Debt -35.1m / FCF TTM 101.4m)
Total Stockholder Equity = 511.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.17% (Net Income 53.0m / Total Assets 860.1m)
RoE = 10.37% (Net Income TTM 53.0m / Total Stockholder Equity 511.3m)
RoCE = 11.40% (EBIT 92.7m / Capital Employed (Equity 511.3m + L.T.Debt 301.5m))
RoIC = 9.71% (NOPAT 71.1m / Invested Capital 732.2m)
WACC = 8.23% (E(1.73b)/V(2.04b) * Re(9.46%) + D(307.5m)/V(2.04b) * Rd(1.73%) * (1-Tc(0.23)))
Discount Rate = 9.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -2.31%
[DCF Debug] Terminal Value 80.51% ; FCFF base≈83.0m ; Y1≈102.4m ; Y5≈174.4m
Fair Price DCF = 108.3 (EV 2.82b - Net Debt -35.1m = Equity 2.85b / Shares 26.3m; r=8.23% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 75.55 | EPS CAGR: 18.61% | SUE: 0.72 | # QB: 0
Revenue Correlation: 70.83 | Revenue CAGR: 13.92% | SUE: -0.14 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.53 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=2.25 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+5.1% | Growth Revenue=+6.0%
EPS next Year (2027-12-31): EPS=2.52 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+12.0% | Growth Revenue=+3.5%